Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02499120
Title Safety And Efficacy Study Of Palbociclib Plus Cetuximab Versus Cetuximab To Treat Head And Neck Cancer
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Pfizer
Indications

oral squamous cell carcinoma

head and neck squamous cell carcinoma

oropharynx cancer

laryngeal squamous cell carcinoma

hypopharynx cancer

Therapies

Palbociclib

Cetuximab

Age Groups: adult
Covered Countries USA | ITA | ESP


No variant requirements are available.